We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAT icon
226
Caterpillar
CAT
$363B
$13.6M 0.08%
34,730
+1,566
+5% +$541K
MOH icon
227
Molina Healthcare
MOH
$10.4B
$13.5M 0.08%
39,314
-31,971
-45% -$10.5M
VLO icon
228
Valero Energy
VLO
$90B
$13.4M 0.08%
99,550
-64,509
-39% -$9.37M
WSM icon
229
Williams-Sonoma
WSM
$27.6B
$13.4M 0.08%
86,617
-36,411
-30% -$5.22M
MRSH
230
Marsh
MRSH
$93.9B
$13.3M 0.08%
59,726
-3,629
-6% -$806K
SE icon
231
Sea Limited
SE
$66.6B
$13.3M 0.08%
+141,123
New +$10.6M
ARQT icon
232
Arcutis Biotherapeutics
ARQT
$3.54B
$13.3M 0.08%
1,426,496
+119,015
+9% +$1.17M
MAC icon
233
Macerich
MAC
$7.43B
$13.1M 0.08%
718,342
+190,090
+36% +$3M
ANNX icon
234
Annexon
ANNX
$811M
$13M 0.07%
2,192,799
+139,340
+7% +$826K
LNTH icon
235
Lantheus
LNTH
$6.52B
$13M 0.07%
118,007
-106,523
-47% -$11.1M
ARVN icon
236
Arvinas
ARVN
$530M
$12.9M 0.07%
524,781
-85,677
-14% -$2.24M
ITT icon
237
ITT
ITT
$17.1B
$12.8M 0.07%
85,910
– –
FERG icon
238
Ferguson
FERG
$43.5B
$12.8M 0.07%
+64,597
New +$13.1M
PYPL icon
239
PayPal
PYPL
$51B
$12.6M 0.07%
161,819
+5,402
+3% +$361K
LBTYK icon
240
Liberty Global Class C
LBTYK
$3.49B
$12.6M 0.07%
581,586
+548,847
+1,676% +$10.8M
PLD icon
241
Prologis
PLD
$135B
$12.5M 0.07%
99,147
+10,985
+12% +$1.36M
AIG icon
242
American International
AIG
$42.5B
$12.4M 0.07%
169,337
-144,979
-46% -$10.8M
CHRW icon
243
C.H. Robinson
CHRW
$20.2B
$12.4M 0.07%
112,227
+93,147
+488% +$9.04M
ROP icon
244
Roper Technologies
ROP
$40.2B
$12.1M 0.07%
21,789
-1,474
-6% -$810K
MLTX icon
245
MoonLake Immunotherapeutics
MLTX
$1.58B
$12M 0.07%
239,000
– –
LBPH
246
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$12M 0.07%
360,789
+134,872
+60% +$4.64M
ITCI
247
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$12M 0.07%
+164,132
New +$12.3M
DELL icon
248
Dell
DELL
$244B
$11.8M 0.07%
99,921
+39,742
+66% +$4.63M
ALGN icon
249
Align Technology
ALGN
$13B
$11.8M 0.07%
46,510
+8,060
+21% +$1.9M
MGA icon
250
Magna International
MGA
$19B
$11.8M 0.07%
287,155
+153,343
+115% +$6.41M
8 9
10
11 12

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.